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1. EP - Ectopic pregnancy. 
2. U.K. - United Kingdom. 
3. CEMD - Confidential Enquiry into Maternal Death. 
4. RCOG - Royal College of Obstetricians and Gynaecologists. 
5. IVF - In vitro fertilization. 
6. ETT – Embryo transfer techniques. 
7. HCG – Human chorionic gonadotropin. 
8. IU/ℓ - International units per litre. 
9. TVS – Transvaginal ultrasonography. 
10.  PAPP-A – Pregnancy associated plasma protein A. 
11.  C.I – Confidence interval. 
12.  R.R – Relative risk. 












OBJECTIVE:   
To describe the patient profile, clinical features, risk factors, management options and 





PLACE AND DURATION OF STUDY: 
 King Edward VIII Hospital, Congella, Durban from   July 2005 – June 2006. 
 
MATERIALS AND METHODS:  
130 case notes of women with the final diagnosis with ectopic pregnancy were 
examined retrospectively. Data was retrieved through a structured proforma. The 
variables studied included age, parity, signs and symptoms, treatment, management, 




One hundred and twenty women diagnosed with ectopic pregnancy were included in 




Women’s ages ranged from 17-40 years with 32 patients (26.7%) being nulliparous and 
88 patients (73.3%) between parity 1-4. Twelve patients (10%) had a history of 
previous ectopic pregnancy. 
 
 The commonest presenting symptom was abdominal pain in 106 (88.3%) patients 
whereas amenorrhoea and vaginal bleeding were found in 88 (73.3%) and 84 (70%) 
patients respectively. 
 
The most common physical sign was tenderness: Adnexal tenderness in 99 (82.5%) 
and pelvic tenderness in 91 (75.8%) of women.    
 
Fourteen women (11.7%) presented to the gynaecological outpatient’s department in 
acute shock with a blood pressure < 90/60 mmHg.  
The commonest ultrasound findings were the presence of an adnexal mass and an 
empty uterus in 82 (68.3%) and 80 (66.7%) women respectively. 
 
 
The most frequent risk factors were previous genital infection in 34 patients (28.3%) 
and multiple sexual partners in 32 patients (26.7%).    
  
One hundred and eleven 92.4%) women were managed by laparotomy:  One hundred 





One patient (0.8%) had a diagnostic laparoscopy which was converted to laparotomy. 
Only 8 patients (6.7%) were managed laparoscopically. 
Surgical treatment consisted of salpingectomy 101/120 (84.9%) and salpingotomy in 4 
(3.4%) patients.  
Post- operation complications were minimal however the one maternal death was 




Risk factors may not always be present, hence ectopic pregnancy should be suspected 
in every women of reproductive age who present with unexplained abdominal pain, 
amenorrhoea and vaginal bleeding. Most women presented with ruptured ectopic 











CHAPTER 1: INTRODUCTION 
 
Ectopic pregnancy is a life threatening condition that every practicing obstetrician and 
gynaecologist encounters in his or her practice. Ectopic pregnancy has become an epidemic, 
and its immediate and delayed sequaelae must not be underestimated.  
 The diagnosis of ectopic pregnancy continues to be a problem in modern gynaecological 
practice.  Sporadic cases of missed diagnosis continue to occur, sometimes leading to grave 
consequences. Many diagnostic algorithms have been proposed for early detection and to 
improve accuracy of diagnosis over the last decade (Koh and Yeo, 2005). However, many 
gynaecologists are not prepared to subject their patients to a stepwise diagnostic algorithm for 
the ill-informed impression that it is unnecessarily wasting time before definite treatment (Koh 
and Yeo, 2005). Its implementation increases the immediate cost and provokes anxiety with 
longer hospital stay, and the patient may default to go to another doctor.  These have to be 
weighed against the potentially disastrous consequences of missing the diagnosis of ectopic 
pregnancy, as well as the medico-legal consequences. 
 
An ectopic pregnancy occurs when the developing blastocyst implants either outside the uterus 
(fallopian tube: ampullary 79.6%; isthmic 12.3%; fimbrial 6.2%, ovary 0.15% and abdominal 
cavity 1.4%) or in an abnormal position within the uterus (cornua 1.9%, cervix 0.15%) 
(Odendaal et al., 2001). Entrapment at the developing blastocyst en route to the uterine cavity 








A ruptured ectopic pregnancy is a medical emergency, therefore it is imperative to diagnose the 
unruptured ectopic pregnancy such that timeous intervention will prevent morbidity and 
mortality. In order to diagnose the unruptured ectopic pregnancy, one has to suspect the 
diagnosis. The introduction of “Early Pregnancy Assessment Units“ (RCOG Guideline Number 
25, October 2006), has rapidly improved  the management of early pregnancy complications, 
facilitated by the use of transvaginalsonography and rapid immunoassay of serum human 


















CHAPTER 2:   
2.1 EPIDEMIOLOGY 
 
Although advances in earlier diagnosis have led to decreased case-fatality rates, and 
conservative laparoscopic treatments have enabled improved outcomes, ectopic pregnancy 
remains a major cause of maternal mortality and accounts for a sizable proportion of infertility 
and ectopic recurrence (Condous, 2004). 
 
Over the last 25 years, as the morbidity and associated mortality of ectopic pregnancy have 
substantially decreased, the incidence has progressively increased (Condous, 2004).  The 
incidence of ectopic pregnancy in the United Kingdom (U.K.) has remained stable in recent 
years (11.1/1000 pregnancies) with nearly 32 000 ectopic pregnancies diagnosed in the U.K. 
within a 3 year period (Lewis and Drife, 1999).  The fourth leading cause of direct maternal 
death in the United Kingdom in the Confidential Enquiry into Maternal Death period 1997-1999 
was ectopic pregnancy, accounting for 80% of first trimester deaths (Lewis and Drife, 1999). 
There were 13 deaths resulting from ectopic pregnancy accounting for 12% of total maternal 
deaths (Lewis and Drife, 1999). 
 
Substandard care was responsible for 65% of these deaths and the most common problem 
was failure to suspect on ectopic pregnancy (Lewis and Drife, 1999). 
 
According to the Sixth report of the Confidential Enquiry into Maternal and Child Health, Why 
Mothers Die?, there were 11 deaths from ectopic pregnancies: 7 located in the extrauterine 





Cornual pregnancies account for approximately 2% of ectopic pregnancies and are said to 
have a high mortality rate between 2.0 – 2.5% (Lewis and Drife, 1999). Ultrasound is 
successful in around 70% at cases but there are well-recognized diagnostic difficulties. In none 
of the cases reported was the diagnosis made before rupture. Haemorrhage can be severe 
because the pregnancies are either more developed than extrauterine tubal pregnancies and 
because of the large blood supply to the uterus (Lewis and Drife, 1999). 
 
According to the Seventh Report of the Confidential Enquiry into Maternal Death (2003-2005), 
there were ten deaths from ruptured ectopic pregnancies. 
Epidemiologists often describe ectopic pregnancy in terms of overall rates rather than absolute 
numbers. Underestimation of this rate results from the sizable percentage of spontaneous 
miscarriages or chemical pregnancies that may actually represent self-resolving ectopic 
gestations. Generally, ectopic pregnancies are quoted in terms of number per reported 
pregnancies. 
 
In South Africa, for the triennium 2002-2004, there were 161 early pregnancy deaths during 
2002-2004 (National Department of Health, 2006).  Ectopic pregnancy attributed to 47 of these 
deaths, a 74% increase on the 27 deaths reported during 1999-2001. It is not clear whether the 
increase in ectopic pregnancy deaths in this triennium is real or the result of improved reporting 
(National Department of Health, 2006). 
 
 Maternal death assessors considered 64% of ectopic deaths to be “clearly avoidable”.  The 
most frequent avoidable factors as were diagnostic problems (31%) and resuscitatory failure in 




The rise and fall in ectopic pregnancy rates could be explained in part by the increasing rates of 
chlamydia infection followed by the effect of prevention and the change in the use of 
intrauterine devices in developed countries (Diamond et al., 1991). 
 
Further, infertility moderately increases the risk of ectopic pregnancy. There is greater 
availability of assisted reproductive technology, surgery performed to correct the tubal factor in 
infertility and widespread use of ovulation induction agents have all been incriminated 
(Diamond et al., 1991). 
 
Reproductive performance following an ectopic pregnancy is adversely affected with a reported 
repeat ectopic rate of 10-27% and subsequent fertility rates of 45-60% (RCOG Guideline 




Historically, clinicians managed ectopic pregnancy by excision via laparotomy.  The first 
successful surgical treatment of salpingectomy was described in 1883 by Tait                  
(quoted by Flystra, 1998). 
 
Since then the traditional surgical approach to ectopic pregnancy has been salpingectomy by 
laparotomy. Conservative surgical treatment of ectopic pregnancy (salpingotomy) in an attempt 
to preserve the affected fallopian tube is thought to be first performed by Prochownick in 1913 
(quoted by Diamond et al., 1991). The first reported salpingotomy was by Stromme in 1953 
(quoted by Flystra, 1998). In 1973, Shapiro and Adler reported the first laparoscopic 
salpingectomy for ectopic pregnancy (quoted by Garry, 1996), while Bruhat reported the first 




Today the availability of monoclonal β-HCG, high resolution transvaginal scan and laparoscopy 
has made it possible to make early diagnosis in many cases before rupture.  This improved 
capability, makes a laparoscopic approach feasible and facilitates conservative surgery, 
particularly in those wishing to conceive again. 
 
Treatment options for ectopic pregnancies are : 
i)    Surgery e.g. salpingectomy or salpingotomy  performed either laparoscopically  or 
      by open surgery. 
ii)   Medical treatment, with a variety of drugs, which can be administered systemically  
      and / or locally by various routes.     
iii)  Expectant management. 
As a consequence, the clinical presentation of ectopic pregnancy has changed from a life 
threatening disease necessitating emergency surgery to a more benign condition in sometimes 











CHAPTER 3:  
3.1 AETIOLOGY 
 
Aetiological factors include : 
i)   Anatomic alterations. 
ii)  Inherent defects in the fertilized ovum. 
iii)  Hormonal imbalance 
 
i)   Anatomic alterations 
Disruption or damage to the mucosal portion of the fimbria or fallopian tube will prevent normal 
embryo transport.  This accounts for about 50% at all ectopic pregnancies                    
(Diamond et al., 1991). Tubal damage is most commonly due to scarring from infection, 
inflammation and surgery. Denudation of tubal epithelium disrupts the normally synchronized 
function of the tubal cilia, particularly within the ampullary portion of the tube, where fertilization 
and early embryo cleavage normally occur. Intraluminal adhesions or diverticulae at any point 
along the tube may interfere with normal pre-embryo transport mechanisms. 
 
ii)  Inherent Defects in the fertilized eggs 
It has been suggested that an increased risk of ectopic pregnancy may reflect instances of 
either premature ovulation, immature eggs (with denser, less motile cumulus-corona 









iii)  Hormonal Imbalance 
Estrogen increases smooth muscle activity and muscular tone in the isthmus of the fallopian 
tube and may facilitate the retention of a fertilized ovum in the ampullary portion of the tube for 
a few days. 
 
Progesterone decreases smooth muscle activity, particularly tubal peristalsis. In the luteal 
phase, progesterone facilitates ovum migration towards the uterus. This may explain the 
increased incidence of ectopic pregnancy in cycles stimulated with human menopausal 
gonadotropin and when pregnancy occurs with a progesterone containing intrauterine device in 
place.  Therefore, the transport of the fertilized ovum through the fallopian tube and 
implantation within the endometrial cavity may require an optimum ratio of estrogen and 
progesterone (Diamond et al., 1991). 
 
 
3.2 PATHOGENESIS AND RISK FACTORS 
 
High risk factors include:  
i) Tubal surgery including sterilization   
ii) Previous ectopic pregnancy   
iii) Use of intrauterine device 
iv) Documented tubal pathology from pelvic inflammatory disease and adhesions from  
previous surgery 





Ectopic pregnancy commonly occurs in patients with impaired tubal function. 
Surgically visualized tubal pathology, commonly the result of pelvic infection,  endometriosis or 
previous surgery is the strongest risk factor.  Pelvic infection, including gonorrhoea, 
serologically confirmed chlamydia infection and pelvic inflammatory disease are less significant 
in a developed setting. In a developing setting the aetiological influence of sexually transmitted 
diseases, which has recently been compounded by the HIV epidemic, impairs tubal function 
leading to dramatically increased incidence (Sperling et al., 1991). The risk of ectopic 
pregnancy increases with the episodes of pelvic infection (Hillis et al., 1997). 
 
Tubal sterilization effectively prevents pregnancy. If pregnancy does occur, ectopic pregnancy 
should be strongly suspected and excluded. Risks appear highest after electrocoagulation 
procedures, possibly resulting from tubal recanalisation or formation of an uteroperitoneal 
fistula (Mc Caussland et al., 1980).  
The risk of ectopic pregnancy after sterilization is increased nine-fold, and is especially high for 
those sterilized by electro-cautery and in women younger than 30 years (Skejeldestad et al., 
1988). A third of pregnancies that arise after sterilization are ectopic (Furlong, 2002). 
 
 
Petersen et al., (1997), reported that 32.9% of pregnancies occurring after prior tubal 
sterilization were ectopic in location. The greater risk occurred in patients who underwent 
laparoscopic tubal bipolar cautery, resulting in an overall ectopic pregnancy risk of   17.1 per 
1000 procedures, but 31.9 per 1000 procedures when biopolar cautery was used before age of 
30 (Kendrick et al. 1997). This is in contrast to a low rate of 1.5 ectopic pregnancies per 1000 





Ectopic pregnancy after tubal sterilization was also more common in black women and in 
women with a history of pelvic inflammatory disease before the sterilization procedure 
(Peterson et al., 1997).  A third of pregnancies that arise after sterilization are ectopic  
(Furlong,2002)  
 
The risk is increased in patients who have had ectopic pregnancy previously, and 
 increases further in proportion to the number of previous ectopic pregnancies.   
 Risk of recurrence decreases with subsequent intrauterine pregnancies after the initial  
  ectopic pregnancy (Skejeldestad et al., 1998). 
 
A woman who is not pregnant and is using a non progesterone-containing intra-uterine device      
is at risk of developing an ectopic pregnancy as a non-pregnant woman not using an 
intrauterine device. However, because an intrauterine device prevents intra-uterine more 
effectively than it prevents extrauterine implantation, a pregnancy occurring with an intrauterine 
device is more often an ectopic pregnancy.  
There maybe a slight increased risk for the future development of ectopic pregnancy in past 
intrauterine device users, and that risk may increase with the duration of use  
(Furlong et al., 2002). 
 
 
Moderate risk factors include: 
  i)  Fertility 
  ii)  Previous genital infection 





Assisted reproduction techniques increase the risk of ectopic pregnancy two-fold to 4% 
(Strandell et al., 1999). The raised likelihood of tubal disease and need for surgery in  
this population are obvious confounders. It has been shown that tubal factor infertility and 
previous myomectomy account for 85% of ectopic pregnancies in women who receive  
fertility treatment (Strandell et al,1999) 
 
Embryo transfer with retrograde embryo migration into diseased tubes is also a reason for the 
higher incidence seen among those undergoing in-vitro fertilization (Nazari et al., 1993). 
 




Low risk factors include:  
i)  Cigarette smoking 
ii)  Vaginal douching 
 
Only a slight increased risk was reported in women who smoked, douched and began coitus at 
an early age. 
  
Kendrick et al.,(1997), reported a strong association between ectopic pregnancy and vaginal 
douching in black women (adjusted odds ratio = 3.8), but could not distinguish douching as an 
independent factor from being an agent promoting a pre-existing infection by forcing non-sterile 





CHAPTER 4:  
 
4.1 DIAGNOSTIC EVALUATION 
 
i) A proper history and physical examination remain the foundation for initiating an    
appropriate workup that will result in the accurate and timely diagnosis of an ectopic               
pregnancy. A third of women have no clinical signs and 9% have no symptoms of                
ectopic pregnancy (Tay et al., 2000). 
 Typical trend of symptoms includes bleeding and abdominal pain after a period of  
amenorrhoea. 
 
ii)   Identification of risk factors can raise the index of suspicion and lend significance to      
otherwise minor physical finding. 
 
iii) Serum-β-HCG measurements - a single measurement of β-hCG in practice will not be 
diagnostic in the majority of cases. An understanding of the pattern of serum β-hCG levels 
in early normal pregnancy is important. At any given time, the serum level of β-hCG is 
determined by the rate of trophoblastic secretion and renal clearance. Given normal renal 
function, β-hCG is cleared from the serum with a half life of about 24 hours (Pittaway et al., 
1985). 
In normal intrauterine pregnancies there should be a 66% rise over the baseline valve over 
48 hour (Kader et al., 1981). Using this well known algorithm is not without its pitfalls, as 
approximately 13% of ectopic and 15% of normal intrauterine pregnancies may exhibit 
declining, a plateau or erratic and unpredictable β-hCG rises (Long et al., 1994). 
Normal intrauterine pregnancies tend to double their β-hCG titres every 2.3 days between 
conception and 7 weeks of gestation. If the appropriate doubling time is not achieved or if 
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the serum concentration of β-hCG plateaus, the pregnancy is either an ectopic or a non 
viable intrauterine pregnancy (Kader et al., 1981). 
 
Kadar et al. (1981) have suggested that non viable intrauterine pregnancies show a more 
rapid fall in serum β-hCG levels than ectopic pregnancies. 
 
Hormonal results should not be taken in isolation and the clinical assessment and 
subsequent ultrasound finding are essential to the ongoing management. 
Since vaginal ultrasound can detect an intrauterine pregnancy about a week earlier than 
that of an abdominal scan, β-hCG levels above 1000 IU/L in the absence of an intrauterine 
sac indicates the need for laparoscopy (Cacciatore et al., 1990). 
The absence of an intrauterine gestational sac and a β-hCG titre between 1000-1500 IU/L 
has been shown to be highly predictive of an ectopic pregnancy (Cacciatore et al., 1990). 
  
iv) Serum Progesterone - serum progesterone levels have been suggested as useful markers 
of ectopic pregnancy, however a systematic review of the accuracy of a single 
progesterone measurement concluded that although the progesterone concentration could 
identify women at risk of ectopic pregnancy, its clinical usefulness is limited because of its 
discriminative capacity to diagnose ectopic pregnancy with certainty (Mol et al., 1998 a ). 
Serum progesterone levels are not gestational age dependent, remain relatively constant 
during the first trimester of normal and abnormal pregnancies and do not correlate with 
hCG levels (Fylstra, 1998). 
Although an absolute cut-off has not been determined, a progesterone level <10 ng/mL is 
generally not compatible with a viable pregnancy. However, a progesterone level >20 




McCord  et al.(1996), in their study of using a single serum progesterone value as a screen 
for ectopic pregnancy, reported that only  0.16% of patients with a progesterone < 5 ng/mL 
(2/1279 patients) eventually were found to have a normal pregnancy and these two patients 
had rising hCG levels. These authors also recommended a progesterone cut-off of 17.5 
ng/mL below which ectopic should be considered (McCord et al., 1996). 
 
v) Biochemical Markers - the ideal marker for ectopic pregnancy would be specific for tubal 
damage or present early after endometrial implantation. Various markers have been 
assessed but none are sufficiently sensitive or specific for the diagnosis of ectopic 
pregnancy (Diamond et al., 1991). 
 
 
vi) Ultrasound - Shalev et al., (1998) state that the diagnosis of ectopic should not be based 
on an inability to visualize an intrauterine pregnancy, but rather on the positive visualization 
of an adnexal mass using transvaginal sonography. If an ectopic pregnancy is present, one 
should visualize between 87-93% of ectopic pregnancies using transvaginal sonography 
(Shalev et al., 1998).  If a pregnancy cannot be seen, then it is a pregnancy of unknown 
location ~ 10% at which are ectopic pregnancies (Condous et al., 2004). 
The appearances of ectopic pregnancies on transvaginal sonography are highly variable. 
Classically, they are described as the “bagel sign” with a hyper echoic ring around the 
gestational sac in the adnexal region, but more often they are seem as a small 
inhomogeneous mass next to the ovary - “blob sign” (Lerner and Monteagudo, 1995). 
 
 A meta analysis (pooled data from 10 published studies) by Brown and Doubilet (1994)   has 
shown that the most appropriate transvaginal criterion on which to diagnose ectopic pregnancy 
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is any non cystic adnexal mass. This leads to a positive predictive value of 96.3%, negative 
predictive value 94.8%, specificity 98.9% and sensitivity 84.9%    (Brown and Doubilet, 1994). 
The dimensions of the ectopic should be described, as should the presence of an embryo with 
or without a heartbeat. 
 
Haematoceles have a characteristic appearance, and the amount of bleeding that has occurred 
should be commented upon by looking for fluid or blood in the pouch of Douglas. This should 
not be confused with serous fluid as the appearance of blood and clots are different. 
 
The corpus luteum is a useful guide when looking for an ectopic pregnancy, as it will be on the 
ipsilateral side in over 85% of cases (Jurkovic et al., 1992). 
 
The so called “pseudosac” is controversial.  This is a misnomer and probably represents a fluid 
collection or debris in the cavity (Condous et al., 2004).  This sign is largely based on historical 
data and relates to the use of transabdominal ultrasonography. Using high resolution vaginal 













Treatment options for tubal ectopic pregnancies are : 
i) Surgery e.g. salpingectomy or salpingotomy either performed laparoscopically or by open 
surgery. 
ii) Medical treatment, with a variety of drugs that can be administered systemically and / or by 
various routes. 
iii) Expectant management   
 
 
LAPAROSCOPY VERSUS LAPAROTOMY 
Laparoscopic surgery is considered by many to be the “gold standard” for surgical treatment if 
the patient is haemodynamically stable (Vermesh et al.,1989). Advances in laparoscopic 
surgery have enabled a laparoscopic approach in the majority of patients with tubal ectopic 
pregnancy. 
 
The laparoscopic approach results in less haemorrhage (blood loss), lower analgesic 
requirement, shorter hospital stay, quicker post operative recovery time and reduce costs 
considerably (Vermesh et al., 1989; Gray,1995). Nevertheless, there will always be a place for 
laparotomy in those women who are haemodynamically unstable. 
 
The subsequent intrauterine pregnancy rate was 61% after laparoscopic surgery compared to 
52% after laparotomy, while the recurrent ectopic pregnancy rate was lower after laparoscopy 




Laparoscopic surgery has been compared with open surgery in 228 women in 3 randomised 
controlled trials. There was no difference in overall tubal pregnancy rates (RR 0.89; 95% CI 
0.74 -1.1) (Vermesh et al., 1989; Lundorff et al., 1991; Gray et al., 1995).  
 
In women who desired future fertility (n = 145), the subsequent intrauterine pregnancy rates 
where similar (RR 1.2; 95%  CI 0.88 -1.15) and there was a trends towards lower repeat 
ectopic pregnancy rates if the laparoscopic approach was used. (RR 0.43; 95%  CI 0.15 – 1.2) 
(Vermesh et al., 1989; Lundorff et al., 1991; Murphy et al.,1992; Gray et al., 1995). 
 
MINILAPAROTOMY VERSUS LAPAROTOMY 
In a study, involving 60 women with an ectopic pregnancy (Sharma et al, 2003) revealed that 
post-operative complications: paralytic ileus (10% vs. 27%) and wound infection (3% vs. 17%) 
were significantly less in the minilaparotomy group than in the conventional laparotomy group.  
Also the duration of hospital stay (3.4 days vs. 6.9 days) was shorter in the minilaparotomy 
group. 
 
SALPINGECTOMY OR SALPINGOTOMY 
There has been considerable debate about whether salpingectomy or salpingotomy should be 
done at the time of surgery for an ectopic pregnancy. 
 
The possible advantages of removing the tube completely include almost entirely eliminating 
the risk of persistent trophoblast and that of subsequent ectopic pregnancy, whereas the 
possible advantage of conserving the fallopian tube is that future fertility is preserved. The 
reported failure rate after conservative treatment ranges from 3 - 29%, whereas there is 




The decision to perform a salpingectomy or salpingotomy will depend on the size of the ectopic 
pregnancy, damage to the tube and the health of the contralateral tube (Ramphal and Moodley, 
2006). 
 
A number of systemic reviews have examined reproductive outcomes following the 
management of tubal pregnancy with either salpingotomy or salpingectomy.   
 
There are no randomized controlled trials comparing outcome and assessing future fertility with 
either form of treatment. 
 
There are four recent cohort studies that specifically compare laparoscopic conservative and 
radical treatment of ectopic pregnancy. 
 
Silva et al.(1993) examined reproductive outcomes prospectively in 143 women undergoing 
laparoscopic salpingectomy (55.9%) or laparoscopic salpingotomy (36.4%) (Silva et al., 1993). 
The intrauterine pregnancy rates were similar when comparing the 2 groups (60% vs. 54% RR 
1.11 95% CI 0.74-1.68) but there was a trend towards higher subsequent ectopic pregnancy in 
the salpingotomy group (18% vs 8%  RR 2.38 95% CI 0.57-10.01)  (Silva et al., 1993). 
 
Job-Spira et al. (1998), in a study of 125 women, performed a multivariate analysis on 
reproductive outcomes following ectopic pregnancy (Job-Spira et al., 1998). They 
demonstrated a trend towards improved subsequent intrauterine pregnancy rates with 
conservative surgery (hazard ratio 1.22 95%  CI 0.68 – 2.20). 
 
The cumulative pregnancy rates at 1 year were 72.4% after conservative and 56.3% after 




In a study by Mol et al.,(1998 b) a cohort of 185 women, the fecundity rate when comparing 
laparoscopic salpingotomy to salpingectomy during the 18 month following period was 1.4 
(95%   CI   0.68 – 2.7) for a women with a healthy contralateral tube and 3.1 (95% CI 0.76-
12.0) for women with contra-lateral tubal disease. 
 
The 3 year cumulative pregnancy rate was 62% after salpingotomy and 38% after 
salpingectomy (Mol et al., 1998 b). 
 
 Bangsgaard et al., found pregnancy rates higher with salpingotomy. The cumulative pregnancy 
rate after 7 years was 89% following salpingotomy and 66% following salpingectomy ( p < 0.05) 
(Bangsgaard et al., 2003). 
 
The hazard ratio for intrauterine pregnancy following salpingectomy was 0.63 (95% CI 0.42- 
0.40 ) when compared to salpingotomy (Bangsgaard et al., 2003). 
 
Conservative surgery should be performed when there is evidence of previous tubal infection at 
the time of laparoscopy, as this confers the best chance for future fertility.  In women with no 
past history of tubal surgery or infertility and those whose contra-lateral tube is normal, the 
fertility results after laparoscopic salpingectomy are comparable to those observed after 
conservative laparoscopic treatment. 
 
Therefore in the presence of a healthy contra-lateral tube, neither salpingostomy nor 
salpingectomy offers any advantage with respect to future infertility. However, in those who 
desire future fertility, salpingostomy should be considered as the primary treatment option for 
tubal pregnancy in the presence of disease in the contra-lateral tube.  
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The patient must be made aware that there is an approximately 20% risk of recurrent ectopic 
pregnancy. If conception has not occurred after 18 months following salpingotomy, it is unlikely 
to occur and in vitro-fertilization should be recommended (Ramphal and Moodley, 2006). 
 
Persistent ectopic pregnancy after laparoscopic salpingotomy varies between 4 - 15% 
(Fernandez and Gerviase, 2004). Therefore, β-hCG concentration should be followed until they 
are undetectable.  
  
 
4.3 MEDICAL MANAGEMENT 
 
Medical treatment with methotrexate is an effective means of treating pregnancy without the 
risks associated with surgery. 
 
Early diagnosis has made medical therapy of ectopic pregnancy an option. Systemic and local 
administration of drugs has been introduced in selected patients with an unruptured tubal 
ectopic pregnancy without active bleeding. Agents that have been used include hyperosmolar 
glucose, urea, cytotoxic agents like methotrexate, prostaglandins and mifepristone.  
 
Methotrexate is a folic acid antagonist that inactivates dihydrofolate reductase, resulting in the 
depletion of tetrahydrofolate, a cofactor essential for deoxyribonucleic acid and ribonucleic acid 
synthesis. The goal of medical management with methotrexate is to selectively kill the 
cytotrophoblast. The body will then spontaneously resorb the remaining products of conception 




Leucovorin, a folinic acid, has been used as a “rescue” medication that allows for higher 
methotrexate dose administration by preventing some of the otherwise prohibitive adverse 
effects. Leucovorin enter cells via a carrier-mediated system and does not require reduction by 
dihydrofolate reductase for conversion to active folate cofactors, preventing some of the 
adverse effects of methotrexate. 
 
Methotrexate maybe administered orally, intramuscularly, intrathecally or by continuous 
infusion. It maybe used as primary treatment, treatment of persistent ectopic after 
salpingotomy, prophylaxis for suggested persistent products of conception after conservative 
surgery and in some cases of unusually located ectopic pregnancies. 
 
Currently there are 2 commonly used protocols for the administration of methotrexate in the 
treatment of ectopic pregnancy. 
 
i) The fixed multiple dose of regimen is derived from the treatment of gestational 
trophoblast disease described by Bagshawe (1989) and Goldstein (1976) (quoted by 
Hajenius et al., 2007) . The regimen of Bagshawe comprise a total of 4 injections of 
methotrexate 50 mg IM alternated with folinic acid 6 mg IM 30 hours after each 
methotrexate injection with a rest period of 6 days. The therapeutic protocol of 
Goldstein comprises of total of 4 injections of methotrexate 1mg/kg IM alternated with 
folinic acid 0.1mg/kg IM 24 hours after each methotrexate injection. 
ii) Alternately, methotrexate can be administered using a “single dose” method (quoted by 
Hajenius et al., 2007). In 1989, Stovall individualized the methotrexate dosage to 
improve patient compliance, to minimize side effects and to reduce overall costs, which 
ultimately led to a single dose regimen of 50 mg/m2 body surface area given 




Each protocol has been demonstrated to have good success rates in uncontrolled independent 
case series. 
 
Large uncontrolled studies involving single dose methotrexate have reported that 15% of 
patients will require more than 1 dose of methotrexate and less than 10% of patients treated 
with this regimen will require surgical intervention. Also 7% of patients will experience tubal 
rupture during follow up (Lipscomb et al., 1994).  
 
SIGNS OF TREATMENT FAILURE / TUBAL RUPTURE 
[ACOG Practice Bulletin 3, 1998 - Medical management of tubal pregnancy] – quoted by Bester 
and Heard, 2000. 
i) Significantly worsening abdominal pain, regardless of change in β-hCG levels. 
ii) Haemodynamic instability. 
iii) Levels of β-hCG do not decline by at least 15% between day 4 and day 7 post injection.  
iv) Increasing or a plateau β-hCG levels after the first week of treatment. 
 
Systematically the efficacy and prevalence of side-effects of the “single” dose and “multidose” 
regimen were compared (Barnhart et al., 2000) 
 
The overall success rate of women treated with methotrexate for an ectopic pregnancy was 
89%. The single dose was much more commonly used. The use of single dose was associated 
with a significantly greater chance of failed medical management than the use of multidose in 
both crude (OR 1.71) and adjusted analysis (OR 4.74). 





COMPLICATION OF METHOTREXATE 
The major adverse effects include liver function, stomatitis, gastro-enteritis and bone marrow 
suppression. Haemorrhage enteritis of the intestinal tract leads to nausea, vomiting, stomatitis, 
elevated liver enzymes, weight loss and blood diarrhoea.   
 
Destruction of bone marrow precursors puts patients at risk of developing thrombocytopaenia, 
reticulacytopaenia, lymphopaenia and granulocytopaenia.  Thrombocytopaenia predisposes 
patients to life-threatening haemorrhage and lymphopaenia and granulocytopaenia that 
predispose patients to systemic infections. 
 
There is also the potential for nephrotoxicity, interstitial pneumonitis, alopecia dermatitis and an 
anaphylactic reaction. 
 
33-60% of patients may experience an increase in abdominal pain 6-7 days after receiving 
methotrexate. The pain is often referred to as separation pain as it is believed to result from 













Revised criteria for medical therapy with methotrexate 
(ACOG Practice bulletin. Medical management of tubal pregnancy) (Number 3, December 
1998). (ACOG Consensus Committee Opinions). 
 
 Indications for methotrexate use 
1. Haemodynamically stable with no signs of tubal rupture. 
2. Diagnosis without laparoscopy. 
3. No contra-indications to methotrexate. 
4. Ectopic mass ≤ 3.5cm. 
5. No fetal cardiac activity  
6. Peak β-hCG < 15000 mIU / ml 




1. Haemodynamic instability. 
2. Medical disease including liver, gastro-intestinal, renal, pulmonary, pre-existing 
haematological, severe immuno-deficiency and history of alcoholism. 
3. Patient refuses medical therapy. 
 
Relative Contra-Indications 
1. Gestational sac > 3.5cm. 






Predictors of Successful Methotrexate Treatment (Lipscomb et al., 1994). 
1. Serum β-hCG concentration is inversely associated with success - this is the most 
predictive. 
 Tawfiq et al., (2000) found that treatment failure occurred in 65% of cases when the β-
hCG was > 4000 IU/l compared with 3.5% when the level was < 4000 IU/l 
2. Progesterone level. 
3. Size and volume of gestational mass. 
4. Presence / absence of cardiac activity. 
5. Presence / absence of free peritoneal blood. 
 
Two recent RCTs compared systemic methotrexate therapy with laparoscopic surgery. 
i) Methotrexate ( 1mg / kg ) versus Conservative laparoscopy surgery  
(Saraj et al., 1998)  
78% success rate for methotrexate compared to 92% for laparoscopic surgery. 
 Methotrexate group 16% required an additional dose 
 
 5% required surgery during follow up period 
 









ii) Methotrexate ( 50 mg / m2 ) versus Conservative laparoscopic surgery 
 (Souter et al., 2001)  
 65 % success rate for single dose methotrexate compared to 
 93% for laparoscopic surgery (95% Cl  10 – 47%) P < 0.05 
Methotrexate group 26% required an additional dose 
 
 18% required surgery  
 
Laparoscopic group 2% persistent trophoblastic tissue 
 
 
Other efforts to attain maximal efficacy while minimizing or eliminating adverse effects resulted 
in various protocols for local medical treatment administered into the gestational sac 
transvaginally under sonographic or under laparoscopic guidance. Since the main advantage of 
medical therapy is its non-invasiveness, intramuscular methotrexate is more practical and less 
operator dependent than local injection via laparoscopy or ultrasound into the sac. The use of 
transvaginal treatment techniques requires a high degree of training and skill, and one would 
not recommend their use, especially in the light of the evidence suggesting that single dose 
methotrexate is just as effective. To evaluate treatment response after medical treatment, close 
serum β-hCG monitoring is mandatory to detect impending failure and inadequately declining 
serum hCG concentrations. 
 
A review of 24 studies found a surgical intervention rate of 9% when methotrexate was injected 
locally into the gestational sac (either laparoscopically / ultrasound guidance) and a rate of 




Reproductive outcome after a previously treated ectopic pregnancy appears to be similar, 
whether the treatment method had been methotrexate or conservative surgery.  Intrauterine 
pregnancy rates seen are comparable in both those groups, with a possible slightly lower risk 
of recurrent ectopic seen in a medically treated group (Fernandez et al., 1998). 
 
The use of mifepristone as an adjunct treatment to methotrexate for ectopic pregnancy showed 
no benefit of the combined regimen over methotrexate alone (Rozenburg et al., 2003). 
The time to resolve the unruptured ectopic was also significantly faster in the group who 
received combination mifepristone and methotrexate (Gazvani et al., 1998). 
 
Overall, it would appear that if strict criteria are fulfilled, medical management is a reasonable 




1. Systemic methotrexate in a single dose versus laparoscopic   salpingostomy 
 
   (Sowter MC, Farquhar CM, Petrie KJ et al, 1998) 
 
 
   Systemic methotrexate ( 50mg/m² / 1 mg/kg im) less successful than  
   Laparoscopic salpingostomy ( RR 0,82 95% CI 0,72-0,94) 
 
 
2.Single versus multiple dose systemic methotrexate 
 
  ( Alleyassin A, Khademi A, Aghahosseini et al, 2006) 
  
 
  Prospective, randomized controlled clinical trial 








3. Systemic methotrexate in combination with mifepristone 
 
  (Rozenberg P, Chevret S, Camus E et al, 2003) 
 
Randomized clinical trial comparing methotrexate-mefiprisone versus methotrexate-placebo 
 
Showed methotrexate (50mg/m²) was less successful in the elimination of tubal pregnancy than 
when mefiprisone 600mg was added 





4.4 EXPECTANT MANAGEMENT  
 
Expectant management has been advocated, based on the knowledge that the natural course 
of many early ectopic pregnancies is a self limiting process, ultimately resulting in tubal 
abortion or reabsorption. 
 
 
In a select group of women, expectant management of ectopic pregnancy is an option.  
Ylostalo et al.(1991), managed  15% of their ectopic pregnancy expectantly and observed 
spontaneous resolution in 64.6%.  An analysis of 10 prospective studies with a total of 347 
patients managed expectantly, demonstrated 69.2% of ectopic pregnancies resolved 








Favourable factors include: 
i) Low initial β-hCG level (1000 – 2000 IU/L). 
ii) Haemoperitoneum < 50 mls. 
iii) Tubal mass < 2 cm. 
iv) Absence of recognizable fetal parts on ultrasound. 
v) Absence of clinical symptoms. 
Such management requires very close follow up and is reserved for selected cases, with after 
hour’s emergency backup in the event of clinical deterioration. 
Royal College of Obstetricians and Gynaecological Guideline include: 
i) Follow up twice weekly with serial hCG measurements (ideally less than 50% of initial 
β-hCG level within 7 days). 
ii) Weekly transvaginal examinations - reduction in the size of the adnexal mass by 7 
days, thereafter, weekly hCG and transvaginal ultrasound examinations are advised 




2 randomized control trials have been published on expectant management for ectopic 
pregnancy. 
 
1.Prostaglandin versus expectant management in early tubal pregnancy 
  (Egarter c, Kiss H & Husslein P, 1991) 
 
 23 patients with unruptured ectopic pregnancy and serum hcg <2500 IU/l 
 
Expectant management was significantly less successful than prostaglandin therapy (RR 0,12 
95% CI 0,02-0,81) 
 
2. Low dose oral methotrexate with expectant management of ectopic pregnancy 
(Korhonen J, Stenman U & Ylostalo P, 1996) 
 
Double blind, placebo controlled trial 
Oral methotrexate 2,5mg/d during 5 days was prescribed: 
-  60 haemodynamically stable women  
-  tubal ectopic pregnancy < 4cm with no fetal heart activity  
-  serum hcg < 5000IU/l 
Success rates of 77% was observed in both groups (RR1,0 95% CI 0,76-1,3) 
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CHAPTER 5: JUSTIFICATION FOR STUDY 
 
Pelvic infections, including Gonorrhoea, serologically confirmed Chlamydia infection and pelvic 
inflammatory disease are common conditions in Southern Africa. Our patients come from a 
poorer socioeconomic background and therefore may be at greater risk for pelvic inflammatory 
disease. Pelvic inflammatory disease together with multiple sexual partners are moderate risk 
factors for ectopic pregnancy. Laparoscopy is regarded as the final decisive test in suspected 
ectopic pregnancy. The new non invasive diagnostic methods of transvaginal sonography and 
serum human chorionic gonadotrophin monitoring now challenge this pivotal role of 
laparoscopy. There are a few studies auditing ectopic pregnancy in Southern Africa. The 
clinical management of patients are still problematic. A significant number of deaths are 
encountered with difficulty in diagnosing ectopic pregnancy. Also the conception rate and 
reproductive performance following ectopic pregnancy is poor. The decision to carry out this 
audit was to allow as an appraisal of clinical practice and to identify areas of potential 












CHAPTER 6: MATERIAL AND METHODS 
 
Systemic audit is now considered to be a hallmark of good clinical practice.  It allows critical 
evaluation of current standards of patient care leads to improvement in clinical practice. 
 
Our study involved a descriptive analysis of the management of ectopic pregnancy at a Durban 
teaching hospital over a period of 1 year. 
130 case notes, including anaesthetic and theatre notes of patients presenting to King Edward 
VIII Hospital, Durban during the period 1 July 2005 to 30 June 2006 with the final diagnosis of 
ectopic pregnancy were examined retrospectively and management was assessed. 
 
Permission to audit all patient clinical files was obtained from the Head of Department of 
Obstetrics and Gynaecology at King Edward VIII Hospital. King Edward VIII Hospital is a 
teaching hospital and serves as a referral hospital for smaller as well as district hospitals. The 
study protocol was reviewed and ethical approval was obtained (reference number E306/05).  
All data was collected on a structured data form (annexure) and was analysed using descriptive 
statistics. Information regarding patient profile, risk factors, presenting symptoms and signs, 
physical examination, ultrasound finding, type of treatment, level of experience of clinician / 
surgeon, complication rates, length of hospital stay and associated maternal morbidity and 
mortality were studied. 
Treatment was grouped into medical or surgical.   
Surgical treatment was grouped into 5 categories: 
i) Emergency laparotomy 
ii) Elective laparotomy 
iii) Emergency laparoscopy 
iv) Elective laparoscopy 
v) Laparoscopy followed by laparotomy 
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Laparoscopic surgical management 
Laparoscopy was performed in only haemodynamically stable patients using 2 or more 
puncture techniques.  The type of laparoscopic surgery depended on the consultant.  
Laparoscopic salpingotomy was performed by making a linear incision using a needle point 
diathermy on the anti-mesenteric boarder of the tube at the maximum distension of the ectopic.  
The trophoblastic tissue was removed with tissue forceps followed by irrigation of the tube with 
saline. 
Laparoscopic salpingectomy was performed either by:  
i) Placing 2 endoloops around the ectopic which is then excised and retrieved using a 
retrieval bag (endobag) 




Laparotomy was performed through a Pfannestiel incision unless the patient had a prior sub 
umbilical midline incision which was excised and laparotomy performed. 
 
The standard management of ectopic pregnancy at King Edward VIII Hospital depends on the 
haemodynamic status of the patient and whether the ectopic pregnancy has ruptured or not. All 
patients are initially resuscitated in the gynaecological outpatient department. Patients who 






In all patients intravenous access is first obtained and baseline investigations include:  
- A full blood count 
- Urea and electrolytes 
- Blood compacting for type and screen 
- Rhesus antigen testing  
- Urine pregnancy test 
- Gynaecological pelvic ultrasound (depending on the stability of the patient) 
Patients diagnosed with unruptured ectopic pregnancies are operated on electively.  
Statistical data is presented in the form of graphs and tables.  
Continuous variables such as age are presented as median and range.  




CHAPTER 7: RESULTS 
 
10 patients were excluded from the study due to failure to obtain correct clinical records or 
inability to complete structured data form due to missing information and records. 
 
The patients ranged in ages from 17 to 40 years, with a mean of 28 years. 





























32 patients (26.7%) were nulliparous and 88 patients (73.3%) were between parity 1-4. There 
were no patients in the category parity 5 and greater (grandmultiparity). 
57 patients (47.5%) gave a history of trying to conceive.  
12 patients (10%) had a history of previous ectopic gestation. 
Signs and symptoms of ectopic pregnancy. 
Values are given as n (%). N = 120 
Table 1: Patient’s symptoms 
       Symptoms Number Percentage 
Abdominal pain 106 88.3% 
Amenorrhoea 88 73.3% 
Vaginal bleeding    84 70.0% 
Syncope   52 43.3% 
Shoulder tip pain 29 24.2% 
Fever     6   5.0% 
 
Table 2: Patient’s signs 
            Signs  Number Percentage 
Abdominal tenderness 26 21.7% 
Pelvic tenderness 91 75.8% 
Adnexal tenderness 99 82.5% 
Adnexal mass 28 23.3% 
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Abdominal pain occurred in 106 patients (88.3%) whereas amenorrhoea and vaginal bleeding 
were present in 88 (73.3%) and 84 (70%) patients respectively. 
 
The modus regarding duration of amenorrhoea was 8 weeks. 
 
The period of amenorrhoea varied from 4½ weeks to 14 weeks, but in 32 (26.7%) patients 
there was no history of a missed period. The greatest duration of amenorrhoea, prior to 
presenting to hospital, was 8 weeks which occurred in 27 (22.5%) patients. This is represented 












Graph 2: Period of amenorrhoea of the study population 
Syncope was present in 52 (43.3%) patients and shoulder tip pain in 29 (24.2%) patients. Only 
6 (5%) patients complained of fever.  
Among the physical signs, abdominal tenderness was present in 26 (21.7%) patients, pelvic 
tenderness 91 (75.8%) and adnexal tenderness was found in 94 (82.5%).  
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In only 28 (23.3%) patients was an adnexal mass appreciable. 
 
Laboratory tests 
The urinary pregnancy test was performed in 119 patients. The test was not performed in 1 
patient because the patient was admitted to hospital as an acute surgical emergency and taken 
to the operating theatre only to diagnose an ectopic gestation intra-operatively. 116 patients 
had a positive test and 3 patients had a negative test.  
6 patients (5%) were rhesus negative.  
Severe anaemia, haemoglobin less than 7 g/dl due to low red cell mass, represented 21 



















Graph 3: Haemoglobin values of the study population 
 
Vital signs:14 patients (11.7%) presented to the gynaecology outpatient room in acute shock 
with a blood pressure < 90/60mmHg. These patients required resuscitation and immediate 















Graph 4: Blood pressure reading of the study population 
17 patients (14.1%) were found to have a pulse > 110 beats/minute. 
Pulse rate recordings are represented in Graph 5. 
5 patients (4.1%) patients had a temperature > 38.0ºC 

































A readily available ultrasound service ensured that all patients could have an ultrasound on the 
same day or by the next working day. 
75 patients (62.2%) had a pelvic ultrasound performed. 
26 patients (21.7%) had a transvaginal ultrasound performed. 
Table 3: Ultrasound findings of the study population 
ULTRASOUND FINDINGS TOTAL NUMBER PERCENTAGE % 
Adnexal mass                82             68.3% 
Empty uterus                80             66.7%   
Fluid in pouch of Douglas                60             50.0% 
Presence of fetal heart pulsation                14             11.7%  
Pseudogestational sac                12              10% 
 
Risk Factors: 
       RISK FACTOR           TOTAL NUMBER           PERCENTAGE% 
Previous sterilization                                   1                   0.83% 
Previous ectopic                                       12                   10.0% 
Previous genital infection                          34                   28.3% 
Multiple sexual partners                            32                    26.7% 
Previous abdominal / pelvic 
surgery      
                      25                    20.8% 
Cigarette smoking                                                           5                    4.2% 





Women diagnosed with ectopic pregnancy can be divided into: 
 Acute ectopic pregnancy  
 Sub-acute ectopic pregnancy (Magara RA, Trew GH, 1997) 
Gynaecology. Churchill Livingston) 
 
 
Classification according to the type of ectopic included 106 patients (88.3%) with acute 
presentation, 14 patients (11,7%) with sub-acute presentation. 
 
87 patients (72.5%) presented with ruptured ectopic pregnancies whilst 33 patients (27.5%) 
presented with unruptured ectopic pregnancies. 
 
119 patients (99.2%) were treated surgically whilst only 1 (0.8%) patient was treated medically. 
The patient treated medically was diagnosed as having an unruptured ectopic pregnancy and 
was treated with systemic methotrexate. 
 
The result of this audit shows that 111 patients (92.4%) are managed via laparotomy in our 
unit. 
104 patients (87.4%)  - managed via emergency laparotomy. 
    6 patients (5%)       - managed via elective laparotomy. 
    1 patient (0.8%)      - had a diagnostic laparoscopy which was converted to  
                                      laparotomy. 
Only 8 patients (6.7%) were managed laparoscopically in our unit. 
In our audit 101/120 (84.9%) patients had salpingectomy performed.  





Other types of surgery included: 
1. Wedge resection   : 9 (7.6%) 
2.  Fimbriectomy     :    3 (2.5%) 
3. Oophorectomy      : 2 (1.7%) 
 






























Type of Surgery 
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The location of the ectopic pregnancies are shown in Table 4 and Graph 7. 
 
Table 4: Location of ectopic pregnancies (n= 120) 
LOCATION             NUMBERS PERCENTAGE % 
Ampullary              78                   65.0% 
Fimbria              20                   16.67% 
Cornua              13                    10.83% 
Tubal:location not specified                7                     5.83% 
Ovary                2                     1.67%  
 
 
Graph 7: Location of ectopic pregnancy in the study population 
The most frequent finding at surgery included pelvic adhesions and ovarian cysts. 
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Table 5: Findings at surgery 
FINDING AT SURGERY              NUMBER PERCENTAGE % 
Pelvic adhesions              18               15% 
Ovarian cysts              12               10% 
Ruptured corpus luteal cyst               9               7.5%  
Fibroids               4               3.3%  
Hydrosalpinx               3               2.8% 
Acute salpingitis               3                2.8% 
Absent tube               2               1.7%      





Graph 8: Other findings at surgery in the study population 
96/120 patients (80%) were operated by registrars alone with assistance provided from medical 
students or medical interns.  
Consultants performed 8.3% of surgery (10/120 patients).  
Registrars together with consultants performed 11.7% of surgery (14/120 patients).  
In only 4/120 cases (3.4%) registrars’ experienced difficulty and consultant help was requested. 
One patient sustained an intra-operative bowel injury (jejunal perforation). A surgeon was 
consulted and the bowel was re-anastomized. 
Majority of the surgery (66.4%) was performed within 6 hours. 
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Table 6: Duration of operation 
TYPE OF OPERATION MEAN RANGE 
Immediate laparotomy 49.5 min 20-120 min 
Elective laparotomy 60.2 min 20 -88 min 
Laparoscopy 88.1 min 45-150 min 
Conversion to laparotomy - - 
 
 
In the diagnostic laparoscopy group which needed conversion to laparotomy, there was only 1 
patient. The operating time in this case was 90 minutes. 
 
In 8/119 patients (6.7%) an abdominal drain (205 tube drain) was inserted intraperitoneally.  
Only 1 patient (0.8%) had a corrugated wound drain, below the skin, inserted. In 96/119 
(80.7%) patients, a peritoneal lavage with normal saline was performed. 
 
Overall 62/120 patients (51.7%) required blood transfusions and 6/120 (5%) patients required 
massive transfusions. 58/120 patients (48.3%) did not required blood transfusions. Table 7 







Table 7: Quantity of blood transfusion 
TRANSFUSION 
TYPE 
QUANTITY NUMBER PERCENTAGE % 
Minor 1-2 units 22 18.3% 
Moderate 3-4 units 34 28.3% 
Major 5 + units 6   5.0% 
 
 
POST OPERATIVE COMPLICATIONS: 
                 Chest infection                                                     3 (2.5%) 
                 Intensive care admission                                     4 (3.4%) 
                 Wound infection                                                         2 (1.7%) 
                 Repeat laparotomy                                                2 (1.7%) 
                 Maternal death                                                       1 (0.8%) 
 
 
Repeat laparotomy was performed due to: 
 Bleeding from  the inferior epigastric artery 
 Suspicion of intra abdominal sepsis 
 
 
Length of stay ranged from 2-14 days. 
Majority of patients were discharged between 3-5 days (78.2%). 







Graph 9: Length of hospital stay in the study population 
107/119 patients were discharged home. 
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CHAPTER 8: DISCUSSION 
 
Ectopic pregnancy is common among first trimester complications. Although the vast majority 
of patients still undergo surgical management, medical therapy with methotrexate is still 
evolving as first line standard practice for unruptured ectopic pregnancy. 
 
Current diagnostic algorithms have been optimally refined. Further diagnostic efficiency will be 
obtainable through more advanced imaging techniques.  
 
The medical literature reporting the treatment of ectopic pregnancy includes mostly 
observational data with very few randomized trials comparing treatment options. Assessment of 
treatment reports is difficult because of selection bias and a paucity of accurate follow-up data 
on future pregnancy outcomes. 
 
This study was undertaken in view of the fact that majority of our patients are brought in as 
emergencies with ruptured ectopic pregnancies and some patients were in a 
haemodynamically unstable condition. 
 
The epidemiological characteristics, symptoms and findings on physical examination of the 
patients in this series of ectopic pregnancies are similar to those found in other series of 
ectopic pregnancy. Lack of consistency in the clinical presentation is an important reason for 
failing to suspect an ectopic pregnancy. 
 
In our study the most consistent single presenting symptom was abdominal pain in 88.3% of 
patients. History of amenorrhoea and vaginal bleeding were present in 73.3% and 70% of 
patients respectively. The most common physical sign was adnexal tenderness in 82.5% 
patients. Abdominal tenderness was found in 21.3% patients, pelvic tenderness 75.8% and an 
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adnexal mass was appreciable in only 23.3% patients. This emphasizes the fact that none of 
the physical signs are specific for ectopic pregnancy. 
 
According to a study by Tay (Tay et al, 2000), abdominal pain was present in 97% of patients 
and vaginal bleeding in only 79% of patients. Abdominal tenderness was reported in 91% and 
adnexal tenderness in only 59% of patients. A study from Nigeria also reported that abdominal 
pain, amenorrhoea and irregular vaginal bleeding were found in 82.6%, 77.5% and 73.7% of 
ectopic pregnancies respectively (Gharoro and Igbafe, 2002). 
 
In our series, the commonest risk factor was previous genital infection and multiple sexual 
partners. Pelvic inflammatory disease has been shown to be a risk factor for ectopic 
pregnancy. Gonococcal infection and multiple sexual partners have been reported to be 
correlated with the occurrence of ectopic pregnancies. A study by Bunyavejchevin et al., 
reported that multiple sexual partners, pelvic inflammatory disease, smoking and infertility were 
the main risk factors of ectopic pregnancy in Thai women (Bunyavejchevin et al, 2003) 
However we did not study the relationship with pelvic inflammatory disease as our patients 
were not screened for Gonorrhoea, Chlamydia trachomatis and Human Immunodeficiency 
Virus. A close association between ectopic pregnancy and infertility does exist. This was not 
found in our study. Previous ectopic pregnancy was a risk factor in 10% of patients and tubal 
surgery (reversal of tubal ligation) in 1 patient. According to a meta-analysis by Mol et al.(1996) 
of risk factors for ectopic pregnancy, a strong association has been reported between ectopic 
pregnancy and those risk factors, affecting the fallopian tube that is previous ectopic, tubal 
surgery, tubal ligation, tubal pathology and in utero diethylstilbestrol. A significant number had 





In our study, no evidence of HIV testing was found in the records. This is surprising in that, the 
HIV pandemic is the highest in the province of KwaZulu-Natal and the opportunity should be 
taken to offer all patients who attend or are admitted to hospital HIV testing. In patients with 
ectopic pregnancy who are haemodynamically unstable, the offer for testing can be done prior 
to discharge from hospital. 
 
Six patients were rhesus negative. Anti-D immunoglobulin at a dose of 50 microgram’s was 
given to all non sensitised patients who were rhesus negative with an ectopic pregnancy. 
 
The last decade has witnessed an increasing number of ectopic pregnancies been managed 
laparoscopically because of the perceived advantages over laparotomy, including reduced 
cost, reduced postoperative opiate requirement, shorter hospital stay and early return to work   
(quoted by Hajenius et al, 2007).Traditionally the treatment of choice for ectopic pregnancy has 
been salpingectomy. Conservative surgery is more likely to be performed if laparoscopic 
surgery is performed. Conservative surgery would depend on other factors, such as the state of 
the affected tube, site of the ectopic pregnancy, whether the ectopic pregnancy is ruptured or 
not and on the patients desire for future fertility. 
 
Laparoscopy is regarded as the decisive diagnostic test in suspected ectopic pregnancy. After 
its introduction in gynaecology, the procedure had a major impact on management of patients 
at risk; it short-circuited the problem of prolonged hospitalization for observation and the risk of 
performing a superfluous laparotomy. 
 
This audit shows that only 6.7% of ectopic pregnancies are managed laparoscopically. Not all 
patients will be suitable for laparoscopic surgery and cardiovascular shock remains a 
contraindication to laparoscopy. The goal is, therefore, to make an early diagnosis before the 
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ectopic ruptures. Our audit revealed a rupture rate of 72.5 %. Among the reasons given for this 
slow uptake of laparoscopic surgery is the need for further training among registrars, 
unpredictability of operating time since we have only one dedicated daytime emergency theatre 
which is shared by all surgical disciplines and the high rate of ruptured ectopic pregnancies. 
 
Adequate training in minimal access surgery is a prerequisite to minimize complications and all 
registrars should be competent in laparoscopic surgery for ectopic pregnancy. 
 
Medical management of only one patient occurred using the “single dose” regimen. This patient 
presented with a 2 x 2 cm right sided adnexal mass and a β-HCG value of 173 mIU/ML. She 
also gave a history of sustaining a left salpingectomy during 2005 for a ruptured ectopic 
pregnancy. Her risk factors included being a smoker and previous pelvic infection.   
 
Clinicians continue to miss the diagnosis of ectopic pregnancy despite an abundance of 
literature and guidelines on the management of ectopic pregnancies in the literature. It cannot 
be over-emphasized that a high index of suspicion is required to consider pregnancy 
complication in any reproductive women with atypical vaginal bleeding or lower abdominal pain. 
There is no single cost effective test to improve the diagnosis of ectopic pregnancy. 6 patients 
were initially misdiagnosed as having threatened miscarriage, only later to present to the 
gynaecology outpatient department as ruptured ectopic pregnancies. 
 
There was one maternal death, suspected to be from a pulmonary embolus within the one year 
audit period; however there was considerable short term morbidity. 14 patients were admitted 
in a condition of shock. 62 patients required blood transfusions and 6 patients required massive 
blood transfusions (5 units of pack cell transfusion and greater). Deaths from ectopic 
pregnancy are not unknown. The 7th report on Confidential Enquiries into Maternal Deaths in 
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the U.K. state that there were 10 deaths due to ectopic pregnancy and the Saving Mothers 
report 2002 - 2004 found that there were 47 deaths mainly due to hypovolaemic shock 
(National Department of Health, 2006).  
 
Four patients required intensive care unit admission for ventilator support secondarily to 
metabolic acidosis from acute blood loss and haemorrhagic shock. Recommendations are that 
patients in haemorrhagic shock following rupture of ectopic pregnancy need to be transferred 
promptly to operating theatre and the transfer must not be delayed by attempts to re-establish a 
normal circulating volume. Time interval between admission and surgery is a crucial factor in 






CHAPTER 9: RECOMMENDATIONS 
A substantial improvement in the quality of care of women with ectopic pregnancy is needed.  
Our targets should include: 
a) Because of the high incidence of tubal ruptures, community education is required to 
inform women to attend health facilities as early as possible once they have symptoms. 
The establishment of early pregnancy units may also result in early diagnosis and 
prevent morbidity. 
b) High rate of sonographic diagnosis of ectopic pregnancy. Sonagraphic equipment 
should be available in all gynaecological emergency units and staff appropriately trained 
to use and interpret the images. 
c) Acceptable rates of tubal conservation. Registrars should be trained to perform 
conservative surgery. 
d) Acceptable rates of laparoscopic surgery in carefully selected patients by improving the 
level of training of junior doctors in laparoscopic surgery and proving the necessary 
equipment and facilities. 
 
Short term surveillance of ectopic pregnancy may need to be done in a highly integrated health 
delivery system where complete ascertainment of cases in a defined population provides the 
coverage and detail to estimate the ectopic pregnancy rate accurately. 
 
Randomised, controlled trials to assess the benefits and harms of expectant management, 
medical management and surgery need to be performed. These studies should include long 
term outcomes of fertility and repeat ectopic pregnancy, health related quality of life, treatment 








PROFILE OF PATIENTS PRESENTING WITH AN ECTOPIC PREGNANCY ATTENDING 
KING EDWARD VIII HOSPITAL, IN DURBAN 
PATIENT PROFILE 
AGE                      [___/___] 
PARITY          [____]  
TRYING TO CONCEIVE               Yes = 1; No = 2   [____]  
HAD FERTILITY TREATMENT     Yes = 1; No = 2   [____] 
PAST OBSTETERIC HISTORY:  
Miscarriage                                      = 1 
TOP                                       = 2 
NVD                                       = 3              [____] 
C/S                 = 4 
Previous ectopic gestation                  = 5 
Gestational trophoblastic disease             = 6 
Heterotrophic pregnancy                           = 7 
 
PRESENTING SYMPTOMS   Yes = 1; No = 2 
Abdominal pain         [____] 
Amenorrhoea                     [____] 
Period of amenorrhoea (weeks)                 [____/____] 
Vaginal bleeding         [____] 
Dizziness / fainting         [____] 
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Pregnancy symptoms         [____] 
Passage of tissue         [____] 
Shoulder tip pain         [____] 
 
PRESENTING SIGNS           Yes = 1;   No = 2 
Abdominal tenderness        [____] 
Pelvic tenderness         [____] 
Adnexal tenderness         [____] 
Adnexal mass          [____] 
Uterine enlargement         [____] 
Orthostatic change         [____] 
Fever           [____] 
                                                                                
INVESTIGATIONS 
Rhesus            Positive = 1;   Negative = 2   [____] 
Haemoglobin                      [____/____] 
Urine β-hCG              Positive = 1;   Negative = 2   [____] 
Serum β-hCG                        [____/____] 
Blood pressure      Systolic           [__________] 
        Diastolic           [__________]      
Pulse                                        [____/____] 
Temperature                         [____/____] 
Ultrasound finding:   
 pelvic / transvaginal   Yes = 1;   No = 2   [____] 
 Pseudo gestational sac   Yes = 1;   No = 2   [____] 
 Adnexal mass                Yes = 1;   No = 2  [____] 
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 Size of mass (cm)                [____] x [____]   
 Fetal heart     Yes = 1;   No = 2   [____]  
 Fluid in Pouch of Douglas   Yes = 1;   No = 2   [____] 
 Empty uterus     Yes = 1;   No = 2   [____] 
 
RISK FACTORS  
High risk: 
  
Tubal surgery                 Yes = 1;   No = 2   [____] 
Sterilization                 Yes = 1;   No = 2   [____] 
Previous ectopic pregnancy               Yes = 1;   No = 2   [____] 
Intrauterine contraceptive device use             Yes = 1;   No = 2   [____] 
Documented tubal pathology               Yes = 1;   No = 2   [____] 
Moderate risk: 
Infertility 
 Fertility treatment : ovulation induction         Yes = 1;   No = 2  [____] 
 IVF                             = 1 
 GIFT                  = 2 
 ZIFT                   = 3  [____] 
 Embryo transfer                 = 4   
 Previous genital infection   Yes = 1;   No = 2  [____] 
 Multiple sexual partner    Yes = 1;   No = 2  [____] 
Slight risk: 
Previous pelvic / abdominal surgery  Yes = 1;   No = 2              [____] 
Cigarette smoking    Yes = 1;   No = 2              [____] 
Vaginal douching     Yes = 1;   No = 2              [____] 
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TYPE OF ECTOPIC 
Acute ectopic       = 1 
Chronic ectopic     = 2 
Acute on chronic ectopic     = 3                [____] 
Suspected ectopic     = 4 
Misdiagnosis      = 5  
 
TREATMENT 
Medical:         Yes = 1; No = 2     
Systematic methotrexate        [____] 
Local injection of methotrexate under u/s guidance                [____] 
Local injection of methotrexate via laparoscopy     [____] 
Surgical:        Yes = 1;   No = 2 
Emergency laparotomy        [____] 
Elective laparotomy                    [____] 
Emergency laparoscopy        [____] 
Elective laparoscopy                    [____] 
Diagnostic laparoscopy converted to laparotomy                [____] 
Type of surgery:      Yes = 1; No = 2 
Complete salpingectomy                  [____] 
Partial salpingectomy                   [____] 
Linear salpingotomy                   [____] 
Linear salpingotomy                   [____] 




Incidence by location: 
Implantation in the fallopian tube: 
o interstitium / cornua   = 1     
o isthmus     = 2     
o ampulla     = 3                [____] 
o fimbria     = 4 
Implantation outside the Fallopian Tube 
o ovary     = 1 
o cervix     = 2 
o abdominal    = 3     [____] 
o ligamentous    = 4 
Other finding at surgery 
 pelvic adhesions    = 1 
 acute salpingo – oophoritis   = 2 
 ruptured corpus luteal cyst   = 3    [____] 
 ovarian cyst     = 4 
 endometriosis     = 5 
 fibroids     = 6 
Level of experience of surgeon 
 Intern with supervision   = 1 
 Medical officer               = 2              [____] 
 Registrar    = 3 




Time diagnosis made:         [__/__h__/__] 
Time of commencement of operation:       [__/__h__/__] 
 
AT SURGERY 
Difficulties at operation    Yes = 1;   No = 2  [____] 
Duration of operation (minutes)          [___/___/___]
  
Usage of abdominal drain     Yes = 1;   No = 2  [____] 
Usage of wound drain    Yes = 1;   No = 2  [____] 
Peritoneal lavage performed    Yes = 1;   No = 2  [____] 
 
COMPLICATIONS  
Blood loss   
 major > 5 units transfused    = 1 
 moderate 3-4 units     = 2             [____] 
 minor 1-2 units      = 3 
Gaseous distension > 48 hours post-operation  Yes = 1;   No = 2 [____] 
Chest infection post-operative    Yes = 1;   No = 2 [____] 
Repeat laparotomy      Yes = 1;   No = 2        [____] 
Wound infection                 Yes = 1;   No = 2  [____] 
ICU admission                 Yes = 1;   No = 2  [____] 





Length of hospital stay (days)                 [____/____] 
If discharged:  
Home                = 1 
 Clairwood Hospital             = 2           [____] 
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